SCHEMBL21736293

SCHEMBL21736293

c1ccc(-n2c3ccccc3c3cc(-c4nc(-n5c6ccccc6c6cc7ccccc7cc65)c5c(n4)oc4ccccc45)ccc32)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 6/20 0.38
LMNA P02545 2/20 0.38
L3MBTL1 Q9Y468 3/20 0.36
KDM4E B2RXH2 1/20 0.36
ATM Q13315 1/20 0.36
NPSR1 Q6W5P4 2/20 0.36
ALDH1A1 P00352 2/20 0.36
CYP1A2 P05177 1/20 0.36
CYP2C9 P11712 1/20 0.36
RAB9A P51151 4/20 0.34
HPGD P15428 2/20 0.34
NPC1 O15118 2/20 0.34
HTT P42858 1/20 0.34
PTGER4 P35408 1/20 0.34
POLB P06746 2/20 0.33
MEN1 O00255 1/20 0.33
MAPK1 P28482 1/20 0.33
DUSP3 P51452 1/20 0.33
PTPN5 P54829 1/20 0.33
KMT2A Q03164 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20670060 0.96 SMN1; SMN2 (0.38) SMN1; SMN2LMNAL3MBTL1KDM4EATM
SCHEMBL16905839 0.95 SMN1; SMN2 (0.41) SMN1; SMN2LMNAL3MBTL1KDM4EATM
SCHEMBL21736055 0.93 SMN1; SMN2 (0.34) SMN1; SMN2LMNAL3MBTL1KDM4EATM
SCHEMBL24772668 0.91 CHEK2 (0.37) SMN1; SMN2LMNAL3MBTL1KDM4EALDH1A1
SCHEMBL21735901 0.91 CHEK2 (0.31) SMN1; SMN2LMNAL3MBTL1ALDH1A1HPGD
SCHEMBL18273484 0.91 SMN1; SMN2 (0.41) SMN1; SMN2LMNAL3MBTL1KDM4EATM
SCHEMBL21735864 0.90 TDP1 (0.32) SMN1; SMN2LMNAL3MBTL1ALDH1A1HSD17B10
SCHEMBL21735860 0.90 TSHR (0.37) SMN1; SMN2LMNAL3MBTL1KDM4ENPSR1
SCHEMBL20669988 0.89 HCRTR1 (0.33) SMN1; SMN2LMNAL3MBTL1KDM4ENPSR1
SCHEMBL19247406 0.89 SMN1; SMN2 (0.41) SMN1; SMN2LMNAL3MBTL1KDM4EATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11530225-B2 Compound and organic light-emitting diode comprising same LG CHEM, LTD. (KR) 2022-12-20 US disclosed
US-20200055865-A1 COMPOUND AND ORGANIC LIGHT-EMITTING DIODE COMPRISING SAME LG CHEM, LTD. (KR) 2020-02-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11530225-B2 Compound and organic light-emitting diode comprising same CRY1, CRY2, TRPA1 SMN1; SMN2 1814/4885LMNA 3949/4885L3MBTL1 433/4885
US-20200055865-A1 COMPOUND AND ORGANIC LIGHT-EMITTING DIODE COMPRISING SAME CRY1, CRY2, TRPA1 SMN1; SMN2 1814/4885LMNA 3949/4885L3MBTL1 433/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.